Press review (July 23, 2011) – Revue de presse (23 juillet 2011)

Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients

Giving the ovaries a rest when young women with breast cancer are undergoing chemotherapy may help prevent early menopause and preserve fertility.

By Amanda Gardner. In U.S. News & World Report

http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/19/drug-may-prevent-chemo-linked-menopause-in-breast-cancer-patients

Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel

A federal advisory committee voted 9 to 6 on Tuesday that a first-of-its-kind diabetes drug should not be approved for use because of safety concerns, including a possible increased risk of breast and bladder cancers.

By Andrew Pollack. In The New York Times

http://www.nytimes.com/2011/07/20/business/diabetes-drug-dapagliflozin-rejected-by-fda-panel.html

Builders in skin cancer warning

Researchers at Manchester University found some construction workers are nine times more likely to get the disease than people doing other jobs.

By Jim Taylor. In BBC News

http://www.bbc.co.uk/newsbeat/14222009

Stem Cells Help Irradiated Mice Grow New Brain Cells

The study could offer hope for brain cancer patients, who often suffer dire cognitive problems as a result of radiation treatment.

By Karen Weintraub. MIT Technology Review

http://www.technologyreview.com/biomedicine/38090/?p1=A2

Link found between male hormone, liver cancer

Androgen, or male hormone, may be responsible for the higher morbidity of liver cancer among men than women, researchers at the Chinese University of Hong Kong (CUHK) have found.

By Andrea Deng. In China Daily

http://www.chinadaily.com.cn/hkedition/2011-07/20/content_12938670.htm

UK cost agency rejects Eisai breast cancer drug (Halaven (eribulin))‎

The National Institute for Health and Clinical Excellence (NICE) said on Wednesday it was not able to recommend the medicine for the treatment of locally advanced or metastatic breast cancer, following chemotherapy.

By Ben Hirschler. Reuters

http://www.reuters.com/article/2011/07/19/eisai-britain-idUSL6E7IJ1W620110719

Herceptin + Chemotherapy Results in Better Survival in HER2-Positive Breast Cancer Patients

Results from a prospective study of 1023 newly-diagnosed HER2-positive metastatic breast cancer patients show that treatment with trastuzumab(Drug information on trastuzumab) (Herceptin) and chemotherapy independently resulted in statistically significant improvement in median overall survival from the time central nervous system (CNS) metastases were diagnosed.

By Anna Azvolinsky. In Cancer Network

http://www.cancernetwork.com/breast-cancer/content/article/10165/1909629

Specialists More Likely to Spot Deadly Skin Cancer

Melanoma, the most dangerous type of skin cancer, can be found by patients themselves, but new research reveals that self-detection is not as effective as screenings performed by doctors.

 In U.S. News & World Report

http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/18/specialists-more-likely-to-spot-deadly-skin-cancer

New lung cancer gene found

Cancer biologists identify a driving force behind the spread of an aggressive type of lung cancer.

By Anne Trafton. MIT News

http://web.mit.edu/newsoffice/2011/lung-cancer-gene-0719.html

Denosumab approved in Europe

Amgen today announced that the European Commission (EC) has granted marketing authorization for denosumab for the prevention of skeletal-related events (SREs) (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.

ecancermedicalscience

http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=1888

Tall people 'more likely to develop cancer'

Being tall has been linked to a greater risk of 10 common cancers by University of Oxford researchers. For every four inches (10cm) above five feet a person was, the researchers said they had a 16% increased cancer risk.

BBC News

http://www.bbc.co.uk/news/health-14230731

Le cancer pourrait se répandre dans les pays pauvres (médecin)

Faute de mesures efficaces comme la mise en place de programmes nationaux de lutte contre le cancer, cette maladie se répandra sous ses différentes formes dans les pays en développement, ceux d’Afrique surtout, a prévenu le cancérologue sénégalais Abdoul Aziz Kassé, samedi à Dakar.

Agence de Presse sénégalaise

http://www.aps.sn/aps.php?page=articles&id_article=82496

Plus de risques de cancer chez les femmes de grande taille

Les femmes de grande taille auraient plus de risques de développer un cancer. Voilà les conclusions d'une étude de l'université d'Oxford publiée dans la revue scientifique The Lancet Oncology.

Dans Le Monde

http://bigbrowser.blog.lemonde.fr/2011/07/22/genetique-plus-de-risques-de-cancer-chez-les-femmes-de-grande-taille/